Clinical Trial: Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Intravitreal Aflibercept (Eylea) for Therapy of Choroidal Neovascularization (CNV) and Fibrovascular Proliferation (FVP) in Patients With Pseudoxanthoma Elasticum (PXE)

Brief Summary: The purpose of this study is to determine whether Aflibercept (Eylea) is effective in the treatment of choroidal neovascularization and fibrovascular proliferation in patients with pseudoxanthoma elasticum (PXE) in terms of preservation or improvement of visual acuity.